Lung cancer signatures in plasma based on proteome profiling of mouse tumor models - Wikidata - wikimedia - TriplyDB

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

http://www.wikidata.org/entity/Q24628852

about

The steady progress of targeted therapies, promising advances for lung cancer From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers Preclinical Murine Models for Lung Cancer: Clinical Trial Applications MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma Molecular portraits: the evolution of the concept of transcriptome-based cancer signatures Protein signature of lung cancer tissues A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening Pro-surfactant protein B as a biomarker for lung cancer prediction.Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.Systems biology approaches to develop innovative strategies for lung cancer therapy.Optimizing mouse models for precision cancer prevention.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Characterization of Niemann-Pick Type C2 protein expression in multiple cancers using a novel NPC2 monoclonal antibody Application of proteomics to cancer early detection Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature.Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.Proteomic challenges: sample preparation techniques for microgram-quantity protein analysis from biological samples.Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets.Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.Proteomics in cancer biomarkers discovery: challenges and applications.Pleural involvement in lung cancer.Identification of urine protein biomarkers with the potential for early detection of lung cancer.Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium The cholesterol-binding protein NPC2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours.Genetic and biochemical alterations in non-small cell lung cancer.Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1)MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis.The orosomucoid 1 protein (α1 acid glycoprotein) is overexpressed in odontogenic myxoma.Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response.Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.Imaging a functional tumorigenic biomarker in the transformed epithelium Multinozzle emitter array chips for small-volume proteomics.Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome.Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses Proteoglycans and their roles in brain cancer.

P2860

Q26746895-D018C95F-44D5-40C0-9010-676DD85B03C7 Q26771375-91A603C0-4A70-40CC-BB78-85B2A1AC0108 Q26863474-4F2590EE-9B81-46FE-A04D-1D4BB08FFEAF Q28480625-6FAB0C2D-11EA-4E7F-92D8-31B5DB6D695E Q28547556-2E50E0AE-F216-491D-9D91-CA2B8D23D122 Q28607220-379B0D7F-25C7-40C5-911F-5C260B2D8EEE Q28730650-E7A521C0-1402-4E14-8903-464B191183FD Q30511822-DF1AA4F3-6B34-4A20-B232-1725827F0918 Q30560535-E0D9247B-2AA9-4737-BCF3-B4ABA0E20B8F Q30600084-9289D525-0CE2-4CB2-854D-392080DF463E Q33720233-6A878F2E-06DB-4223-B5E6-852453D867B9 Q33919192-38FBFDAC-2CC0-44AF-BC12-CB4F8684618C Q34350615-931C233B-6F2D-422C-8224-CA2D39721C91 Q35023240-7C48AE7E-4A4E-45F7-A0E5-0DA9A815505A Q35053031-8F6BA0D0-C2FE-4320-B349-897B92751B5C Q35070288-7F6244F8-69FF-4B23-A31B-7317C84E2D9C Q35127253-826A3973-4F77-4F75-8BB2-25710DC87CB1 Q35139099-65C2C32B-AEEA-4E92-8942-101F7120E588 Q35180727-39F72067-98D1-47D8-B579-BAC8CADB6984 Q35429274-3C28B761-191E-4C8C-9A66-0B887837B621 Q35492010-AD7C5BD4-4A8D-4BC8-9150-80C90A8CB6A2 Q35592114-80296B20-CDEE-4FBA-809D-0A51AE8F758D Q35739559-5A191676-1917-4E95-AA56-528BEB257217 Q35809192-9B62C9D5-883E-433B-A77E-4865A5643CC4 Q35957217-9F1EB274-E4EF-4241-AE10-03F28E798A45 Q36057569-BE5CDB52-3B85-455D-A422-5E4B5DD22844 Q36184584-7D33A013-A7BD-49A8-9EC9-8D4B8FD202C2 Q36217272-C7E7755F-AF42-467E-8E98-FE0DD27C6634 Q36249105-220BB53F-A096-470C-ACAB-E06E6281E18E Q36297407-5A3DE0A0-E9B4-4AD6-82C5-BB0F84BDD55D Q36365669-2597DAC8-F78F-4A93-8C9A-390645798DF5 Q36383987-9E6CD242-4315-4C65-9A42-F460F67A91F7 Q36407251-9E99B627-A10B-464C-B074-236A92C8D67F Q36443870-CF682C16-E749-4511-B77E-EBBE3071D497 Q36512410-0401F11A-6A12-408D-989B-3437F85A7FF4 Q36537798-A98A26D9-D679-4D17-AEA4-628694721616 Q36615870-96ED655D-27EB-4572-BFED-C9AAA1927857 Q36710603-591DBF43-4646-44D1-A289-FE38A2B892EE Q36808014-0494D0B3-DD79-4029-BA63-BA3FD557EBFC Q36816444-B66ECBF2-8947-4F37-BABE-3C9B65D89FC1

P2860

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

http://www.wikidata.org/entity/Q24628852

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@ast

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@en

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@nl

type

label

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@ast

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@en

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@nl

prefLabel

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@ast

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@en

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@nl

P1433

Q24628852-F9560A30-7E07-4904-A2CE-0D7E3B1CE2D6

P1476

Q24628852-C179F7DA-0CBB-483D-843D-D2A240AECDE8

P2093

Q24628852-01B588F4-188C-4C81-B6C0-7841C1E8EA16

Q24628852-0648D948-9A59-4918-A135-885F582C53AA

Q24628852-16A51657-F153-4D45-8D97-BF2BA6577D47

Q24628852-19852EB3-8B6E-41B1-AD3B-70CA9A327B4E

Q24628852-1BCD12B4-F6F0-463E-A7DB-C3F32C36334B

Q24628852-3665F521-AFEF-4499-9200-93B7955751C7

Q24628852-45824F98-1F72-4955-BBD4-92843FFD0483

Q24628852-54605B56-ED08-4479-AA38-A5ED9B3BFEB8

Q24628852-92AF0F25-1BAD-4A55-BBD2-76A46F0A4774

Q24628852-A320C7D5-8EB7-4B89-9AFD-BACEFFB427F3

P2860

Q24628852-0513C9C9-50E8-402D-9E10-1FA674150A6C

Q24628852-09FC8240-09A9-4B0F-94E2-13DA71861DA0

Q24628852-0ADB4F07-30F2-4C1E-9BFD-100CC580C582

Q24628852-0E02D3A7-CD84-4AAF-828C-FC6A17897D79

Q24628852-0E71EEC6-996B-4E6F-8167-0E5FFCC96F05

Q24628852-0EE9B368-52F3-4048-BD89-B7B0F86E329D

Q24628852-0F1D7C51-2F5E-430C-8D79-D29E598F8B5D

Q24628852-1902F8EF-B46F-478E-807C-A5506D8870F7

Q24628852-19C4D468-F285-4DED-8916-EC1BB8F35FA4

Q24628852-1C9A6ACC-8AB2-4B45-9DBA-ED79414EB94A

P304

Q24628852-BDFEBB2C-3139-4152-BCCF-0B36342E5795

P31

Q24628852-31FA5D0D-FC9F-4318-8222-7B3045758F7D

P3181

Q24628852-23FC9FF2-62F5-48EB-92D3-DF15FBFBD663

P356

Q24628852-51A93F10-77FD-4A1E-B558-BC985CC4D141

P407

Q24628852-E96C150E-32F6-45E2-8F07-4AB5BDD4ADA2

P433

Q24628852-F04FDFF8-522E-4C3F-AA68-2DB1F5FBA985

P478

Q24628852-DCBC0A8D-FF11-4CFC-BB37-E754AA605C73

P50

Q24628852-0562DA12-686E-4D46-B156-B51DCD4ED990

Q24628852-527E7B82-F425-4D29-9002-4C209F593606

Q24628852-67662053-BAD3-4747-A8A2-BB8B11E29859

Q24628852-7B12CC00-0C10-48E8-B679-85C5C600DB11

Q24628852-9584D0D6-89E0-4483-92CF-842302E0E849

P577

Q24628852-6F8D3C69-1AD9-4A2C-BA21-F7A053B8A8A9

P5875

Q24628852-B5DD9AEB-14CF-4337-9EF8-25E7B04EC890

P698

Q24628852-7544B1C2-5A45-4D2F-985A-B9454A99241E

P921

Q24628852-1AEB29D9-BB3E-4B32-8928-35F38B66C701

P932

Q24628852-ABA28D49-C921-465E-A178-8C4F5F76FC08

P3181

P356

J.CCR.2011.08.007

P1433

P1476

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

@en

P2093

Adi F Gazdar

http://www.w3.org/2001/XMLSchema#string

Alice Chin

http://www.w3.org/2001/XMLSchema#string

Chee-Hong Wong

http://www.w3.org/2001/XMLSchema#string

Christopher J Kemp

http://www.w3.org/2001/XMLSchema#string

Daniela M Dinulescu

http://www.w3.org/2001/XMLSchema#string

Gary Goodman

http://www.w3.org/2001/XMLSchema#string

Karen Kelly-Spratt

http://www.w3.org/2001/XMLSchema#string

Kwon-Sik Park

http://www.w3.org/2001/XMLSchema#string

Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Raju Kucherlapati

http://www.w3.org/2001/XMLSchema#string

P2860

WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung

ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo

ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing

Cluster analysis and display of genome-wide expression patterns

Characterizing the cancer genome in lung adenocarcinoma.

Identification of a Sam68 ribonucleoprotein complex regulated by epidermal growth factor

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity

CD44: from adhesion molecules to signalling regulators

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

P304

289-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1999630

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CCR.2011.08.007

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Harold E. Varmus

Sharon J Pitteri

Katerina Politi

P577

2011-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51639380

http://www.w3.org/2001/XMLSchema#string

P698

21907921

http://www.w3.org/2001/XMLSchema#string

P921

P932

3406925

http://www.w3.org/2001/XMLSchema#string